Claritas Pharmaceuticals (formerly Kalytera Therapeutics) to Focus on Development of R-107 as a Therapy for Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections – #stocks chatter

0
203

Claritas Pharmaceuticals (formerly Kalytera Therapeutics) to Focus on Development of R-107 as a Therapy for Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections

https://ca.finance.yahoo.com/news/claritas-pharmaceuticals-formerly-kalytera-therapeutics-123000138.html

LEAVE A REPLY

Please enter your comment!
Please enter your name here

eight − 7 =

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.